Development of potent water-soluble inhibitors of the DNA-dependent protein kinase (DNA-PK)

被引：0
|
作者：
Cano, C. [1 ]
Curtin, N. J. [1 ]
Golding, B. T. [1 ]
Haggerty, K. [1 ]
Hardcastle, I. R. [1 ]
Hummersone, M. [2 ]
Menear, K. [2 ]
Richardson, C. [2 ]
Smith, G. C. M. [2 ]
Griffin, R. J. [1 ]
机构：
[1] No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] KuDOS Pharmaceut Ltd, Cambridge, England
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72059-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [1] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
    Cano, Celine
    Bailey, Chris
    Bardos, Julia
    Curtin, Nicola
    Frigerio, Mark
    Golding, Bernard
    Hardcastle, Ian
    Hummersone, Marc
    Menear, Keith
    Newell, David
    Saravanan, Kappusamy
    Shea, K.
    Smith, Graeme
    Griffin, Roger
    CANCER RESEARCH, 2010, 70
  • [2] Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)
    Barrett, Lauren
    Rennison, Tommy
    Clapham, Kate M.
    Rodriguez-Aristegui, Sonsoles
    Bardos, Julia
    Curtin, Nicola J.
    Dennis, M.
    Finlay, Ray
    Golding, Bernard T.
    Hardcastle, Ian R.
    Newell, David R.
    Young, Gail
    Cano, Celine
    Griffin, Roger J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [3] Development of potent inhibitors of the DNA-dependent protein kinase (DNA-PK)
    Cano, Celine
    Curtin, Nicola
    Hardcastle, Ian
    Golding, Bernard
    Smith, Graeme
    Newell, Herbie
    Griffin, Roger
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [4] Development of potent inhibitors of DNA-dependent protein kinase (DNA-PK)
    Clapham, K. M.
    Rennison, T.
    Rodriguez-Aristegui, S.
    Bardos, J.
    Curtin, N. J.
    Golding, B. T.
    Hardcastle, I. R.
    Newell, D. R.
    Cano, C.
    Griffin, R. J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 140 - 140
  • [5] Design and synthesis of novel DNA-dependent protein kinase (DNA-PK) inhibitors
    Barbeau, OR
    Golding, BT
    Griffin, RJ
    Hardcastle, IR
    Smith, GCM
    Richardson, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2718 - U2718
  • [6] Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
    Clapham, Kate M.
    Rennison, Tommy
    Jones, Gavin
    Craven, Faye
    Bardos, Julia
    Golding, Bernard T.
    Griffin, Roger J.
    Haggerty, Karen
    Hardcastle, Ian R.
    Thommes, Pia
    Ting, Attilla
    Cano, Celine
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (33) : 6747 - 6757
  • [7] 8-biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
    Murr, Marine Desage-El
    Cano, Celine
    Golding, Bernard T.
    Hardcastle, Ian R.
    Hummersome, Marc
    Frigerio, Mark
    Curtin, Nicola J.
    Menear, Keith
    Richardson, Caroline
    Smith, Graeme C. M.
    Griffin, Roger J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4885 - 4890
  • [8] DNA-BINDING BY THE THE HUMAN DNA-DEPENDENT PROTEIN-KINASE, DNA-PK
    POLTORATSKY, V
    MALIK, N
    SAMSON, G
    LIEBER, M
    CARTER, T
    FASEB JOURNAL, 1995, 9 (06): : A1394 - A1394
  • [9] Regulation of the DNA-dependent protein kinase (DNA-PK) activity in eukaryotic cells
    Muller, C
    Calsou, P
    Frit, P
    Salles, B
    BIOCHIMIE, 1999, 81 (1-2) : 117 - 125
  • [10] The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight
    LeesMiller, SP
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (04): : 503 - 512
12345